Stay
up-to-date
about
RECOVER
Our understanding of Long COVID is constantly evolving with new research findings. Stay informed by reading the latest news and participating in upcoming events.
RECOVER research continues to advance our understanding of how and why Long COVID can affect everyone differently.
During the February 11th RECOVER Research Review (R3) Seminar, Dr. Grace McComsey (Case Western Reserve University) and Dr. Kristine Erlandson (University of Colorado Anschutz Medical Campus) discussed how biomarkers – signs of disease that can be observed and measured – may provide information that will improve researchers’ ability to understand, diagnose, prevent, and treat Long COVID. Dr. McComsey and Dr. Linda Geng (Stanford University) also discussed recent updates to and findings from the RECOVER-Adult Long COVID Research Index.
A recent RECOVER study found that women had a 31% higher risk for developing Long COVID than men. Findings from this study may help identify who is at a higher risk for developing Long COVID and potential Long COVID treatments.
Over the last two years, RECOVER Patient, Caregiver, and Community Representatives have helped plan and write more than 100 publications about RECOVER’s Long COVID research and its findings.
During the January 28th RECOVER Research Review (R3) Seminar, Dr. Kellie Owens, PhD (NYU Grossman School of Medicine) shared ethical guidance for enrolling individuals in clinical studies who have direct involvement with the research. Dr. Owens was joined by co-authors Leah Castro, MA (RECOVER Community and Caregiver Representative) and Rebecca Letts (RECOVER Patient and Caregiver Representative), who described Representatives’ important role in designing RECOVER clinical studies and developing peer-reviewed research publications.
RECOVER researchers found that people were more likely to develop myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) after having COVID-19. Most of the people who developed ME/CFS also developed Long COVID.
RECOVER researchers analyzed 59 Long COVID research studies to identify gaps in understanding, preventing, diagnosing, and treating Long COVID in older adults.
Six people who are contributing to RECOVER now also serve on the U.S. Secretary for Health and Human Services’ Advisory Committee on Long COVID, providing recommendations regarding Long COVID and associated conditions.
Results from a recent RECOVER study suggest that adults who have COVID-19 may be more likely to develop a related condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Media InquiriesAre you a member of the media or press? Please direct inquiries to the RECOVER@nih.gov inbox. Please place "MEDIA INQUIRY" in your subject line.